What is it?
 Speech:  
HONcode sites All Web sites HONselect News Conferences Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2008: A J J M A M F J
2007: D N O S

 

     Posting date: 29-Jul-2008

 
Other news for:
Aging
Alzheimer Disease
Sex Hormones
Hormones
Thyroid Gland
Resources from HONselect
Thyroid Hormone May Boost Women's Alzheimer's Risk
Low and high thyrotropin levels associated with disease incidence, but not in men

By Robert Preidt

TUESDAY, July 29 (HealthDay News) -- High or low levels of the hormone thyrotropin may be associated with an increased risk of Alzheimer's disease in women. Thyrotropin affects thyroid gland function and thyroid hormone levels.

Between 1977 and 1979, researchers at Beth Israel Deaconess Medical Center and Harvard Medical School measured thyrotropin levels in 1,864 people, average age 71, without cognitive problems. The participants were then assessed for dementia every two years.

After an average of 12.7 years of follow-up, 209 participants developed Alzheimer's disease. After they adjusted for the other factors, the researchers found that women with the lowest (less than one milli-international unit per liter) and highest (more than 2.1 milli-international units per liter) levels of thyrotropin had more than a twofold increased risk of Alzheimer's.

No association between thyrotropin levels and Alzheimer's risk was noted in men.

"Whether altered thyrotropin levels occur before or after onset of Alzheimer's disease, the neuropathologic mechanism is unclear," the study authors wrote.

Brain changes caused by Alzheimer's disease may cause a decrease in the amount of thyrotropin released or changes in the body's responsiveness to the hormone, the researchers said. Or, it may be that high or low thyrotropin levels damage neurons or blood vessels, resulting in cognitive problems.

"In conclusion, low and high thyrotropin levels were associated with an increased risk of incident Alzheimer's disease in women but not in men. These findings should be considered hypothesis-generating and should be validated in other populations before clinical conclusions are drawn," the researchers wrote.

The study was published in the July 28 issue of the journal Archives of Internal Medicine .

More information

The U.S. National Institute on Aging has more about Alzheimer's disease .

SOURCE: JAMA/Archives journals, news release, July 28, 2008

Copyright © 2008 ScoutNews, LLC . All rights reserved.URL:http://www.healthscout.com/template.asp?id=617873

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img Contact img MediaCorner img HONewsletter img Ethical policy img Site map
HON Foundation is an NGO in Special Consultative Status with the Economic and Social Council of the United Nations
/News/HSN/617873.html
Last modified:  Aug 26 2008 © HON 2008